Roles of neuroactive amino acids in ammonia neurotoxicity

Journal of Neuroscience Research

Volumn 51, Issue 2, 1998, Pages 133-138

  Albrecht, Jan ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Ammonia; Benzodiazepines; GABA; Glutamate; Neurotoxicity; Receptors; Taurine

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; AMINO ACID; AMMONIA; AMPA RECEPTOR; ARGININE; BENZODIAZEPINE DERIVATIVE; CARRIER PROTEIN; GLUTAMATE RECEPTOR; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; PREGNENOLONE; TAURINE;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASTROCYTE; COMA; HEPATIC ENCEPHALOPATHY; HYPERAMMONEMIA; NERVE ENDING; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SHORT SURVEY; STUPOR;

AMMONIA; ANIMALS; HUMANS; NERVOUS SYSTEM DISEASES; NEUROTRANSMITTER AGENTS;

EID: 0032518360     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980115)51:2<133::AID-JNR1>3.0.CO;2-E     Document Type: Short Survey

References (74)

1. Albrccht J (1996): Astrocytes and ammonia neurotoxicity. In Aschner M, Kimelberg HK feds): "The Role of Glia in Neurotoxicity." Boca Raton, FL: CRC Press, pp 137-153.
2. +-ATPase activity and GABA uptake in astroglial cell-enriched fractions and synaptosomes derived from rats in the early stage of experimental hepatogenic encephalopathy. Acta Neurol Scand 72:317-320.
3. Albrecht J, Hilgier W, Łazarewicz JW, Rafałowska U, Wysmyk-Cybula U (1988: Astrocytes in acute hepatic encephalopathy: metabolic properties and transport function. In Norenberg MD, Hertz L, Schousboe A (eds): "Biochemical Pathology of Astrocytes." New York: Alan R. Liss, Inc., pp 465-476.
4. Albrecht J, Hilgier W, Rafałowska U (1990): Activation of arginine metabolism to glutamate in rat brain synaptosomes in thioacetamide-induced hepatic encephalopathy: an adaptive response? J Neurosci Res 25:125-130.
5. Albrecht J, Bender AS, Norenberg MD (1994): Ammonia stimulates the release of taurine from cultured astrocytes. Brain Res 660:228-232.
6. Anholt RRH, Pedersen PL, DeSouza EB, Snyder S (1986): The peripheral type benzodiazepine receptor: localization to the mitochondrial outer membrane. J Biol Chem 261:576-583.
7. Basile AS (1991): The contribution of endogenous benzodiazepine receptor ligands to the pathogenesis of hepatic encephalopathy. Synapse 7:141-150.
8. A receptor complex in an experimental model of hepatic encephalopathy: evidence for elevated levels of an endogenous benzodiazepine receptor ligand. J Neurochem 53:1057-1063.
9. Basile AS, Harrison PM, Hughes RD, Gu ZQ, Pannell L, McKinney A, Jones EA, Williams R (1994): Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy. Hepatology 19:112-121.
10. Bender AS, Norenberg MD (1996): Effects of ammonia on L glutamate uptake in cultured astrocytes. Neurochem Res 21:567-573.
11. Borkowska HD, Oja SS, Saransaari P, Albrecht J (1997): Release of [3H] dopamine from striatal and cerebral cortical slices from rats with thioacetamide-induced hepatic encephalopathy: different responses to stimulation by potassium ions and agonists of ionotropic glutamate receptors. Neurochem Res 22:101-106.
12. Bruce JH, Neary JT, Itzhak Y, Norenberg MD (1995): Ammonia inhibits the metabotropic glutamate receptor in cultured astrocytes. Soc Neurosci Abstr 21:1081.
13. Conn HO, Bircher J (1994): "Hepatic Encephalopathy: Syndromes and Therapies." Bloomington, IN: Medi-Ed Press.
14. Cooper AJL, Plum F (1987): Biochemistry and physiology of brain ammonia. Physiol Rev 67:440-519.
15. 3H-MK801 to the MK801 binding site of the N-methyl-D-aspartate receptor during experimental encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit. Metab Brain Dis 8:81-94.
16. Desjardin P, Bandeira P, Rao VLR, Ledoux S, Butterworth RF (1997): Increased expression of the peripheral-type benzodiazepine receptor-isoquinoline carboxamide binding protein mRNA in brain following portacaval anastomosis. Brain Res 758:255-258.
17. Ducis I, Norenberg LOB, Norenberg MD (1989): Effect of ammonium chloride on the astrocyte benzodiazepine receptor. Brain Res 493:362-365.
18. Faff L, Reichenbach A, Albrecht J (1996): Ammonia-induced taurine release from cultured rabbit Muller cells is an osmoresistant process mediated by intracellular accumulation of cyclic AMP. J Neurosci Res 46:231-238.
19. Faff L, Reichenbach A, Albrecht J (1997): Two modes of stimulation by ammonia of taurine release from cultured rabbit Muller cells. Neurochem Int 31:301-305.
20. - ions and relation to cell volume changes. Glia 10:114-120.
21. Fan P, Szerb JC (1993): Effects of ammonium ions on synaptic transmission and on responses to quisqualate and N-methyl-D-aspartate in hippocampal CA1 pyramidal neurons in vitro. Brain Res 632:225-231.
22. Fan P, Lavoie J, Le NLO, Szerb JC, Butterworth RF (1990): Neurochemical and electro-physiological studies on the inhibitory effect of ammonium ions on synaptic transmission in slices of rat hippocampus: evidence for a postsynaptic action. Neuroscience 37:327-334.
23. Giguere J-F, Hamel E, Butterworth RF (1992): Increased densities of binding sites for the mitochondrial benzodiazepine receptor ligand 3II-PK-11195 in rat brain following portacaval anastomosis. Brain Res 585:295-298.
24. Hermenegildo C, Marcaida G, Montolm C, Grisolla S, Minana MD, Felipo V (1996): NMDA receptor antagonists prevent acute ammonia toxicity in mice. Neurochem Res 21:1237-1244.
25. 3H]D-aspartate from hippocampal slices distinguishes encephalopathy related to acute liver failure from that induced by simple hyperammonemia. Brain Res 567:165-168.
26. Hilgier W, Olson JE, Albrecht J (1996): Relation of taurine transport and brain edema in rats with simple hyperammonemia or liver failure. J Neurosci Res 45:69-74.
27. Holopainen I, Oja SS, Marnela KM, Kontro P (1986): Free amino acids of rat astrocytes in primary culture: changes during cell maturation. Int J Dev Neurosci 4:493-496.
28. Iles JF, Jack JJB (1980): Ammonia: assessment of its action on postsynaptic inhibition as a cause of convulsions. Brain 103:555-578.
29. Itzhak Y, Norenberg MD (1994): Regulation of peripheral-type benzodiazepine receptors in cultured astrocytes by monoamine and amino acid neurotransmitters. Brain Res 660:346-348.
30. Itzhak Y, Norenberg MD (1994): Attenuation of ammonia toxicity in mice by PK 11195 and pregnenolone sulfate. Neurosci Lett 182:251-254.
31. Itzhak Y, Baker L, Norenberg MD (1993): Characterization of the peripheral-type benzodiazepine receptors in cultured astrocytes: evidence for multiplicity. Glia 9:211-218.
32. Itzhak Y, Roig-Cantisano A, Dornbro RS, Norenberg MD (1995): Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. Brain Res 705:345-348.
33. Katchman AN, Hershkowitz N (1997): Nitric oxide modulates synaptic glutamate release during anoxia. Neurosci Lett 228:50-54.
34. Knecht K, Michalak A, Rose C, Butterworth RF (1996): Decreased glutamate transporter (GLT-1) gene expression in brain in acute liver failure [Abstract]. Hepatology 24:486.
35. Koh JY, Palmer E, Cotman CW (1991): Activation of the metabotropic glutamate receptors attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures. Proc Natl Acad Sci USA 88:9431-9435.
36. + -ATPase. J Neurochem 63:2172-2178.
37. Kosenko E, Kaminsky Y, Grau E, Miňana MD, Grisolia S, Felipo V (1995): Nitroarginine, an inhibitor of nitric oxide synthetase, attenuates ammonia toxicity and ammonia-induced alterations in brain metabolism. Neurochem Res 20:451-456.
38. Lavoie J, Pomier-Layrargues G, Butterworth RF (1990): Increased densities of "peripheral-type" benzodiazepine receptors in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Hepatology 11:874-878.
39. Lombardi G, Mannaioni G, Leonardi P, Cherici G, Carla V, Moroni F (1994): Ammonium acetate inhibits ionotropic receptors and differentially affects metabotropic receptors for glutamate. J Neural Transm 97:187-196.
40. Maddison JE, Watson WEJ, Dodd PR, Johnston GAR (1991): Alterations in cortical [3H]kainate and α-[3H]amino-3-hydroxy-5-methyl-4 isoxazolepropionic acid binding in a spontaneous canine model of chronic hepatic encephalopathy. J Neurochem 56:1881-1888.
41. Majcwska MD (1992): Neurosteroids: endogenous bimodal modulators of the GABA-A receptor: mechanism of action and physiological significance. Prog Neurobiol 38:370-395.
42. Marcaida G, Felipo V, Hermenegildo C, Miňana MD, Grisolia S (1992): Acute ammonia neurotoxicity is mediated by the NMDA type of glutamate receptors. FEBS Lett 296:67-68.
43. Marcaida G, Miňana MD, Burgal M, Grisolia S, Felipo V (1995): Ammonia prevents activation of NMDA receptors by glutamate in rat cerebellar neuronal cultures. Eur J Neurosci 7:2389-2396.
44. +-ATPase that results in its activation in cerebellar neurons in culture. J Neurochem 66:99-104.
45. Martin DL (1992): Synthesis and release of neuroactive substances by glial cells. Glia 5:81-94.
46. Mena EE, Cotman CW (1985): Pathologic concentrations of ammonium ions block L-glutamate uptake. Exp Neurol 59:259-263.
47. 3H]5-fluorowillardiine in the brains of rats with acute liver failure. Hepatology 25:631-635.
48. Michalak A, Rose C, Butterworth J, Butterworth RF (1996): Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure. Hepatology 24:908-913.
49. Miňana MD, Marcaida G, Grisolia S, Felipo V (1995): Prenatal exposure of rats to ammonia impairs NMDA receptor function and affords delayed protection against ammonia toxicity and glutamate neurotoxicity. J Neuropathol Exp Neurol 54:644-650.
50. Miňana MD, Hermenegildo C, Llansola M, Montoliu C, Grisolia S, Felipo V (1996): Carnitine and choline derivatives containing a trimethylamine group prevent ammonia toxicity in mice and glutamate toxicity in primary cultures of neurons. J Pharmacol Exp Ther 279:194-199.
51. Moroni F, Lombardi G, Moneti G, Cortesini C (1983): The release and the neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy. J Neurochem 40:850-854.
52. Moroni F, Lombardi G, Carla V, Pellegrini D, Carassale GL, Cortesini C (1986a): Content of quinolinic acid and of other tryptophan metabolites increases in brain regions of rats used as experimental models of hepatic encephalopathy. J Neurochem 46:869-874.
53. Moroni F, Lombardi G, Carla V, Lal S, Etienne P, Nair NP (1986b): Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure. J Neurochem 47:1667-1671.
54. Mousseau DD, Baker GB, Butterworth (1997): Increased density of catalytic sites and expression of brain monoamine oxidase a in humans with hepatic encephalopathy. J Neurochem 68:1200-1208.
55. Mullen KD, Szauter KM, Kaminsky-Russ K (1990): "Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet i:81-83.
56. Norenberg MD (1996): Astrocytic ammonia interactions in hepatic encephalopathy. Semin Liver Dis 16:245-253.
57. Norenberg MD, Huo Z, Neary JT, Roigh-Cantesano A (1997): The glial glutamate transporter in hyperammonemia and hepatic encephalopathy: relation to energy metabolism and glutamatergic transmission. Glia, 21:124-133.
58. Oja SS, Saransaari P, Wysmyk U, Albrecht J (1993): Loss of GABAB binding sites in the cerebral cortex of rats with acute hepatic encephalopathy. Brain Res 629:355-357.
59. Oppong KNW, Bartlett K, Record CO, Mardini HA (1995): Synaptosomal glutamate transport in thioacetamide-induced hepatic encephalopathy in the rat. Hepatology 22:553-558.
60. Peterson C, Giguere J-F, Cotman CW, Butterworth RF (1990): Selective loss of N-methyl-D-aspartate binding sites in rat brain following portacaval anastomosis. J Neurochem 55:386-390.
61. Pomier-Layrargues G, Giguere JF, Lavoie J, Perney P, Gagnon S, D'Amour M, Wells J, Butterworth RF (1994): Flumazenil in cirrhotic patients in hepatic coma: a randomized double blind placebo controlled crossover trial. Hepatology 19:32-37.
62. Raabe W (1989): Neurophysiology of ammonia intoxication. In Butterworth RF, Pomier Layrargue G (eds) Hepatic Encephalopathy: Pathophysiology and Treatment. Clifton, NJ: Humana Press, pp. 49-77.
63. Raabe W (1992): Ammonium ions abolish excitatory synaptic transmission between cerebellar neurons in primary dissociated tissue culture. J Neurophysiol 68:93-99.
64. Rao VLR, Murthy ChRK (1991): Hyperammonemic alterations in the uptake and release of glutamate and aspartate by rat cerebellar preparations. Neurosci Lett 130:49-52.
65. 3H] arginine uptake in brain following portacaval anastomosis. J Neurochem 65:677-681.
66. 3H] nitroarginine into rat brain synaptosomes. J Neurochem 68:337-343.
67. +-ATPase activities are increased in brain in both congenital and acquired hyperammonemic syndromes. Neurosci Lett 197:89-92.
68. 3H]MK801 binding sites in brain in congenital ornithine transcarbamylase deficiency. Metab Brain Dis 10:249-255.
69. Rothstein JD (1994): Benzodiazepine-receptor ligands and hepatic encephalopathy: a causal relationship? Hepatology 19:248-250.
70. Saransaari P, Oja SS, Borkowska HD, Kostinaho J, Hilgier W, Albrecht J (1997): Effects of thioacetamide-induced hepatic failure on the N-methyl-D-aspartate receptor complex in the rat cerebral cortex, striatum and hippocampus: binding of different ligands and expression of receptor subunit mRNAs. Mol Chem Neuropathol (in press).
71. Szerb JC, Butterworth RF (1992): Effect of ammonium ions on synaptic transmission in the mammalian central nervous system. Prog Neurobiol 39:135-153.
72. Tossman J, Delin A, Eriksson LS, Ungerstedt U (1987): Brain cortical amino acids measured by intracerebral dialysis in portacaval shunted rats. Neurochem Res 12:265-269.
73. Vogels BAPM, Maas MAW, Daalhuisen J, Quack G, Chamuleau RAFM (1997): Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology 25:820-827.
74. Wysmyk U, Oja SS, Saransaari P, Albrecht J (1994): Long-term treatment with ammonia affects the content and release of taurine in cultured cerebellar astrocytes and granule neurons. Neurochem Int 24:317-322.